Image

Emily Clarke

Associate

Emily Clarke is an Associate at Wilkinson Stekloff.  Before joining the firm, she was a law clerk to the Honorable D. Michael Fisher of the U.S. Court of Appeals for the Third Circuit and a litigation associate at Milbank.

Emily attended Georgetown University Law Center, where she served as Managing Editor of the American Criminal Law Review and President of the Women’s Legal Alliance. While studying at Georgetown, Emily was a member of the Appellate Litigation Clinic and successfully briefed a case before the U.S. Court of Appeals for the D.C. Circuit. She received the International Academy of Trial Lawyers award for her work. Emily also was a member of the moot court team and served as a judicial intern to Judge James E. Boasberg of the U.S. District Court for the District of Columbia.


Education

  • Undergraduate: Clemson University, B.A. & B.S., summa cum laude (2017)
  • Law: Georgetown University Law Center, J.D., cum laude (2020); International Academy of Trial Lawyers Award; President, Women’s Legal Alliance; Managing Editor, American Criminal Law Review

Clerkship

  • Judge D. Michael Fisher, U.S. Court of Appeals for the Third Circuit (2021-2022)

Notable Matters

  • Member of the trial team that secured a groundbreaking victory for Microsoft, defeating the FTC’s efforts to enjoin its $68.7 billion acquisition of Activision Blizzard and winning the second-biggest merger trial in American history. Following a five-day bench trial, Judge Jacqueline Scott Corley denied the FTC’s motion for preliminary injunction, finding that the FTC failed to make its case that the acquisition would substantially lessen competition in the gaming industry. Member of the team that subsequently directed post-trial strategy, in which Microsoft defeated the FTC’s motions in trial court and the district court to enjoin the transaction pending an appeal, clearing the path for the deal to close.
  • Member of the trial team in a consolidated product liability case for a major consumer product/pharmaceutical company.